Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Research & Development

1594

The term research and development (R&D) refers to work that is done in order to better understand the nature, function or understanding of a topic or product in order to gain knowledge and find new applications for existing products or to develop new and innovative products. This is usually performed by corporations, government agencies, and research or academic institutions.

New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce.

In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.

Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.

RSS Feeds

All reports in Research & Development

< prev 1  2  3  4  5  6  7  8  9  10  next >
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
5/15/2012 | published by: GBI Research
... research, “Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity”, which provides insights into the global orphan diseases in genetic disorders therapeutics ...  |  more...
$3,500.00
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
... target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the ...  |  more...
$3,995.00
Biotechnology and Pharmaceuticals Report
4/30/2012 | published by: Wall Street Transcript
... interviews with 3 leading Analysts; and top management from 2 Sector Firms. Topics covered: Biotech Stocks Outperformance and Rally - FDA Drug Approval Process - M&A Activity Acceleration in 2012 - U.S. Health Care Regulation ...  |  more...
$175.00
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
4/30/2012 | published by: GBI Research
... its latest research “Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments”, which provides insights into autoimmune disease therapeutics ...  |  more...
$3,500.00
Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth
4/30/2012 | published by: GBI Research
... Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth”. The report focuses on the current scenario of orally administered drugs. Key segment of orally administered drugs ...  |  more...
$3,500.00
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules
4/30/2012 | published by: GBI Research
... latest research “Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules”, which provides insights into the Oncology orphan disease therapeutics ...  |  more...
$3,500.00
Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation
4/30/2012 | published by: GBI Research
... “Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation”, which provides insights into the orphan disease therapeutics market until 2018. The report ...  |  more...
$3,500.00
Plunkett's Engineering & Research Industry Almanac 2012: Engineering & Research Industry Market Research, Statistics, Trends & Leading Companies
4/30/2012 | published by: Plunkett Research, Ltd.
... companies Industry Glossary Buyer may register for access to search and export data at Plunkett Research Online Pages: 711 Statistical Tables Provided: 25 Companies Profiled: 488 Geographic Focus: Global A complete market research report, including ...  |  more...
$299.99
Plunkett's Engineering & Research Industry Trends & Statistics 2012: A Summary of Plunkett's Engineering & Research Industry Almanac 2012
4/30/2012 | published by: Plunkett Research, Ltd.
... at Plunkett Research Online Pages: 76 Statistical Tables Provided: 25 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Engineering & Research Industry Almanac 2012, including forecasts and market estimates, technologies analysis and ...  |  more...
$149.99
Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion
4/30/2012 | published by: GBI Research
... Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion”, which provides insights into the cytotoxic therapies market until 2017 for eight oncology indications. The ...  |  more...
$3,500.00
Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
4/20/2012 | published by: GBI Research
... Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs”, which provides key data, information and analysis of the Contract Manufacturing Organization (CMO) industry. The ...  |  more...
$3,500.00
Clinical Trials Market in India 2012
4/13/2012 | published by: Netscribes (India) Pvt. Ltd.
... the country’s lower costs and various other advantages. Moreover, many domestic pharmaceutical companies as well have increased their R&D spending for new drug development and are outsourcing clinical trials to various CROs. With this rapid ...  |  more...
$795.00
Vendor Assessment: 2011 Top 10 Life Science Software Vendors
4/9/2012 | published by: IDC
... life science software vendors list includes expanded insights into life science vendor rankings within the life science industry subsegments, research, development, manufacturing and supply chain, and sales and marketing. Eric Newmark, program director at IDC ...  |  more...
$4,500.00
Orphan Diseases Therapeutics in CNS to 2017 - Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington’s Disease Segment
4/2/2012 | published by: GBI Research
... its latest research “Orphan Diseases Therapeutics in CNS to 2017 - Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington’s Disease Segment”, which provides insights into the CNS orphan ...  |  more...
$3,500.00
Chinese Markets for Hepatitis Drugs
4/1/2012 | published by: Asia Market Information & Development Company
... investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in ...  |  more...
$4,000.00
Top 700 Medical & Scientific Research (Global)
4/1/2012 | published by: Plimsoll Publishing Ltd.
... other and compared to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new ...  |  more...
$1,500.00
Backup Compound Strategies: Commercial and Tactical Considerations - Overview
4/1/2012 | published by: CHI Insight Pharma Reports
... significant investments. Planning optimal backup compound strategies is often difficult. This Insight Pharma Report: Describes how companies are addressing strategic and tactical issues concerning backup compounds and predicts how they are likely to do so ...  |  more...
$9,950.00
Fragment-Based Drug Discovery: Technologies, Applications, and Pipelines - Overview
4/1/2012 | published by: CHI Insight Pharma Reports
... Drug Discovery: Technologies, Applications, and Pipelines, examines the many issues that must be considered vis-à-vis employment of fragment-based screening approaches. Chemical considerations are examined, including the impact of high-throughput screening (HTS) and its attendant shortcomings, ...  |  more...
$795.00
Strategic Analysis of the U.S. Research Antibodies Market
3/30/2012 | published by: Frost & Sullivan
... detection and quantification of particular targets within a sample. Provided within the study is a detailed history and market overview, important market metrics, key market drivers and restraints, and an analysis on competitive dynamics and ...  |  more...
$6,000.00
Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future
3/23/2012 | published by: GBI Research
... for Approved Products Reflects a Pessimistic R&D Future”, provides in-depth analysis of the unmet need, drivers, and barriers that impact the global urological disorders market. The report analyzes the markets for urological disorders in the ...  |  more...
$3,500.00
Neurometabolic Disorders Market to 2017 - Novel Therapies for Rare Diseases such as Gaucher’s and Niemann-Pick Poised to Supersede Existing Therapies
3/23/2012 | published by: GBI Research
... Novel Therapies for Rare Diseases such as Gaucher’s and Niemann-Pick Poised to Supersede Existing Therapies” which provides insights into global neurometabolic disorders market and market forecast until 2017. Report is built using data and information ...  |  more...
$3,500.00
White Paper: Clinical Trial Outsourcing in BRIC Countries
3/22/2012 | published by: Kalorama Information
... Paper provides a brief look at Outsourcing in Brazil, Russia, China and India.  It is based on the information in our report.  Outsourcing in Drug Development: The Clinical Trial, CRO Market, available from Kalorama Information.  |  more...
Research Report on Chinese Bio-pharmaceutical Industry, 2012
3/21/2012 | published by: China Research and Intelligence Co., Ltd.
... bio-pharmaceutical industry. "Bio-pharmaceutical" in the report only refers to human biological products. Chinese biological product industry is an emerging industry which has only over 20 years of history. In 2011, the sales revenue of Chinese ...  |  more...
$3,000.00
Scientific Research & Development in the US - Industry Market Research Report
3/21/2012 | published by: IBISWorld
... shifting funding sources have changed the type of research being performed. Historically, government money has been devoted mostly to basic research, meaning research without a specific goal. On the other hand, private and corporate money ...  |  more...
$910.00
Ophthalmic Drugs: World Market Prospects 2012-2022
3/16/2012 | published by: Visiongain
... study investigates prescription drugs treating human eye diseases. It lets you assess forecasted sales trends at world market, therapeutic submarket, product and national level to 2022. How will 20 leading ophthalmic drugs - including Lucentis, ...  |  more...
$2,642.00
< prev 1  2  3  4  5  6  7  8  9  10  next >